Novo Nordisk
NVO
#30
Rank
HK$2.329 T
Marketcap
HK$527.31
Share price
-1.23%
Change (1 day)
-49.59%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): HK$156.72 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$43.76 Billion. In 2024 the company made an earning of HK$148.33 Billion, an increase over its 2023 earnings that were of HK$120.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$156.72 B5.65%
2024 HK$148.33 B22.75%
2023 HK$120.83 B57.64%
2022 HK$76.65 B5.35%
2021 HK$72.76 B12.47%
2020 HK$64.69 B13.07%
2019 HK$57.21 B-3.35%
2018 HK$59.20 B1.79%
2017 HK$58.15 B4.52%
2016 HK$55.64 B9.42%
2015 HK$50.85 B8.24%
2014 HK$46.98 B3.45%
2013 HK$45.41 B19.02%
2012 HK$38.15 B15.21%
2011 HK$33.12 B17.71%
2010 HK$28.13 B24.78%
2009 HK$22.55 B10.62%
2008 HK$20.38 B55.97%
2007 HK$13.06 B7.07%
2006 HK$12.20 B18.18%
2005 HK$10.32 B11.33%
2004 HK$9.27 B
2002 HK$6.15 B-14.39%
2001 HK$7.19 B-52.82%
2000 HK$15.24 B250%
1999 HK$4.35 B31.21%
1998 HK$3.31 B34.31%
1997 HK$2.47 B11.46%
1996 HK$2.21 B9.03%
1995 HK$2.03 B-3.15%
1994 HK$2.09 B-0.67%
1993 HK$2.11 B45.38%
1992 HK$1.45 B-13.81%
1991 HK$1.68 B37.12%
1990 HK$1.23 B-0.79%
1989 HK$1.23 B26.2%
1988 HK$0.98 B24.97%
1987 HK$0.78 B-0.9%
1986 HK$0.79 B-7.78%
1985 HK$0.86 B24.87%
1984 HK$0.68 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$80.98 B-48.67%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$106.51 B-32.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$47.83 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$68.76 B-56.41%๐Ÿ‡ซ๐Ÿ‡ท France